BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2257120)

  • 1. Effect of recombinant human TNF on human ovarian cancer cell lines.
    Vigani A; Miglietta L; Chiara S; Repetto L; Pichi E; Cimoli G; Morelli L; Poggi L; Billi G; Parodi S
    Boll Soc Ital Biol Sper; 1990 Jun; 66(6):537-42. PubMed ID: 2257120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effect of tumor necrosis factor-alpha- and diphtheria toxin-mediated cytotoxicity in sensitive and resistant human ovarian tumor cell lines.
    Morimoto H; Safrit JT; Bonavida B
    J Immunol; 1991 Oct; 147(8):2609-16. PubMed ID: 1918981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous response of human colon cancer cells to the cytostatic and cytotoxic effects of recombinant human cytokines: interferon-alpha, interferon-gamma, tumor necrosis factor, and interleukin-1.
    Morikawa K; Fidler IJ
    J Biol Response Mod; 1989 Apr; 8(2):206-18. PubMed ID: 2499665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to TRAIL-induced apoptosis in ovarian cancer cell lines is overcome by co-treatment with cytotoxic drugs.
    Tomek S; Horak P; Pribill I; Haller G; Rössler M; Zielinski CC; Pils D; Krainer M
    Gynecol Oncol; 2004 Jul; 94(1):107-14. PubMed ID: 15262127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytotoxicity of recombinant human tumor necrosis factor (rHTNF) alone and in combination with chemotherapeutic agents on human ovarian cancer cells].
    Zhao EF
    Zhonghua Fu Chan Ke Za Zhi; 1993 Mar; 28(3):153-6, 188. PubMed ID: 8354095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-proliferative effects of tumor necrosis factor and gamma interferon on human ovarian cancer cell lines].
    Li J; Liu YL; Sha JY
    Zhonghua Fu Chan Ke Za Zhi; 1994 Nov; 29(11):670-2, 700. PubMed ID: 7712890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential induction of apoptosis by tumor necrosis factor-related apoptosis-inducing ligand in human ovarian carcinoma cells.
    Lane D; Cartier A; L'Espérance S; Côté M; Rancourt C; Piché A
    Gynecol Oncol; 2004 Jun; 93(3):594-604. PubMed ID: 15196850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Synergistic effects of tumor necrosis factor interferon-gamma and chemotherapeutic drugs on human ovarian cancer cell lines in vitro].
    Li J; Hui N; Zhu L
    Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):429-31. PubMed ID: 8697994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of "atypical"-multidrug resistance by recombinant human tumor necrosis factor in the human ovarian cancer cell line A2780-DX3.
    Cimoli G; Valenti M; Parodi S; Mazzoni A; De Sessa F; Conte P; Russo P
    Oncol Res; 1993; 5(8):311-23. PubMed ID: 8012063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of TNF alone or in combination with chemotherapeutic agents on human ovarian cancers in vitro and in nude mice.
    Zhao E; Zhou M; Fu C; Shen B; Zhang Q; Lian L
    Chin Med J (Engl); 1995 Aug; 108(8):571-5. PubMed ID: 7587485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An in vitro and in vivo study of antitumor effects of rHTNF-alpha on human ovarian cancer].
    Zhao EF; Zhou MQ; Fu CY
    Zhonghua Zhong Liu Za Zhi; 1994 Jul; 16(4):273-6. PubMed ID: 7805556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of antineoplastic effects by the combination of recombinant human tumor necrosis factor and mitoxantrone on primary culture of human ovarian cancer cells.
    Cimoli G; Valenti M; Venturini M; Conte P; Russo P
    Anticancer Res; 1992; 12(5):1411-4. PubMed ID: 1444198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of TNF-alpha-regulated COX-2 expression in ovarian cancer cells.
    Yang WL; Roland IH; Godwin AK; Xu XX
    Oncogene; 2005 Dec; 24(54):7991-8002. PubMed ID: 16044148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
    Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression.
    Wu S; Boyer CM; Whitaker RS; Berchuck A; Wiener JR; Weinberg JB; Bast RC
    Cancer Res; 1993 Apr; 53(8):1939-44. PubMed ID: 8385577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma and tumor necrosis factor-alpha induce synergistic cytolytic effects in ovarian cancer cell lines-roles of the TR60 and TR80 tumor necrosis factor receptors.
    Kost ER; Mutch DG; Herzog TJ
    Gynecol Oncol; 1999 Mar; 72(3):392-401. PubMed ID: 10053112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of drug-resistant human ovarian tumor cell lines to combined effects of tumor necrosis factor (TNF-alpha) and doxorubicin: failure of the combination to modulate the MDR phenotype.
    Safrit JT; Berek JS; Bonavida B
    Gynecol Oncol; 1993 Feb; 48(2):214-20. PubMed ID: 8428693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure to enhance the in vivo killing of human ovarian carcinoma by sequential treatment with dequalinium chloride and tumor necrosis factor.
    Manetta A; Emma D; Gamboa G; Liao S; Berman M; DiSaia P
    Gynecol Oncol; 1993 Jul; 50(1):38-44. PubMed ID: 8349163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of interferon induction of class I major histocompatibility complex antigen expression by human tumor necrosis factor in small cell lung cancer cell lines.
    Marley GM; Doyle LA; Ordóñez JV; Sisk A; Hussain A; Yen RW
    Cancer Res; 1989 Nov; 49(22):6232-6. PubMed ID: 2553249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of lysosomal activity with sensitivity and resistance to tumor necrosis factor in murine L929 cells.
    Liddil JD; Dorr RT; Scuderi P
    Cancer Res; 1989 May; 49(10):2722-8. PubMed ID: 2713856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.